2021 Q4 Form 10-K Financial Statement

#000143774922007930 Filed on April 01, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2021 2020 Q4
Revenue $934.9K $5.114M $1.060M
YoY Change -11.8% 80.27% 100.0%
Cost Of Revenue $372.1K $1.673M $310.0K
YoY Change 20.02% 110.48% -53.73%
Gross Profit $562.9K $3.442M $750.0K
YoY Change -24.95% 68.54% -676.92%
Gross Profit Margin 60.21% 67.3% 70.75%
Selling, General & Admin $1.752M $6.028M $1.770M
YoY Change -1.0% 3.07% 4.73%
% of Gross Profit 311.32% 175.16% 236.0%
Research & Development $809.9K $2.355M $410.0K
YoY Change 97.53% 68.65% 13.89%
% of Gross Profit 143.88% 68.43% 54.67%
Depreciation & Amortization $63.00K $54.65K $130.0K
YoY Change -51.54% -36.27% 116.67%
% of Gross Profit 11.19% 1.59% 17.33%
Operating Expenses $2.562M $8.383M $2.180M
YoY Change 17.53% 15.71% 6.86%
Operating Profit -$1.999M -$4.942M -$1.430M
YoY Change 39.81% -5.02% -34.1%
Interest Expense -$29.70K $18.00K -$20.00K
YoY Change 48.5% -99.59% -95.0%
% of Operating Profit
Other Income/Expense, Net $0.00 -$123.9K $0.00
YoY Change -97.23%
Pretax Income -$2.029M -$5.066M -$1.440M
YoY Change 40.9% -47.61% -84.89%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.029M -$5.066M -$1.440M
YoY Change 40.9% -47.64% -84.89%
Net Earnings / Revenue -217.02% -99.06% -135.85%
Basic Earnings Per Share -$0.65
Diluted Earnings Per Share -$260.1K -$650.1K -$184.4K
COMMON SHARES
Basic Shares Outstanding 7.834M 7.792M 62.41M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.754M $7.754M $17.51M
YoY Change -55.72% -55.72% 2867.8%
Cash & Equivalents $7.754M $7.754M $16.99M
Short-Term Investments $0.00 $0.00 $510.0K
Other Short-Term Assets $49.50K $216.0K $60.45K
YoY Change -18.12% 8.02% -45.51%
Inventory $4.941M $4.941M $330.9K
Prepaid Expenses
Receivables $970.6K $970.6K $548.0K
Other Receivables $131.5K $131.5K $350.0K
Total Short-Term Assets $14.01M $14.01M $18.94M
YoY Change -26.02% -26.01% 1286.37%
LONG-TERM ASSETS
Property, Plant & Equipment $69.17K $323.3K $81.79K
YoY Change -15.44% -43.29% -14.36%
Goodwill $1.263M $1.263M
YoY Change 0.0%
Intangibles $1.298M $1.514M
YoY Change -14.27% 880.75%
Long-Term Investments $452.8K $452.8K
YoY Change
Other Assets $257.7K $257.7K $170.0K
YoY Change 51.6% 51.6% -29.17%
Total Long-Term Assets $3.756M $3.756M $3.579M
YoY Change 4.96% 4.92% 216.58%
TOTAL ASSETS
Total Short-Term Assets $14.01M $14.01M $18.94M
Total Long-Term Assets $3.756M $3.756M $3.579M
Total Assets $17.77M $17.77M $22.52M
YoY Change -21.1% -21.1% 802.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $427.8K $427.8K $244.2K
YoY Change 75.2% 78.24% -71.09%
Accrued Expenses $829.0K $1.006M $508.5K
YoY Change 63.03% 35.97% -11.24%
Deferred Revenue $565.4K $657.3K
YoY Change -13.99% 83.0%
Short-Term Debt $0.00 $0.00 $232.0K
YoY Change -100.0% -100.0%
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $1.999M $1.999M $1.876M
YoY Change 6.56% 6.35% -57.27%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $154.3K $154.3K $310.0K
YoY Change -50.24% -50.24% -20.51%
Total Long-Term Liabilities $154.3K $154.3K $309.2K
YoY Change -50.1% -50.24% -20.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.999M $1.999M $1.876M
Total Long-Term Liabilities $154.3K $154.3K $309.2K
Total Liabilities $2.154M $2.154M $2.185M
YoY Change -1.46% -1.66% -54.3%
SHAREHOLDERS EQUITY
Retained Earnings -$104.6M -$99.51M
YoY Change 5.09% 10.91%
Common Stock $786.00 $782.00
YoY Change 0.51% 329.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.62M $15.62M $20.34M
YoY Change
Total Liabilities & Shareholders Equity $17.77M $17.77M $22.52M
YoY Change -21.1% -21.1% 802.01%

Cashflow Statement

Concept 2021 Q4 2021 2020 Q4
OPERATING ACTIVITIES
Net Income -$2.029M -$5.066M -$1.440M
YoY Change 40.9% -47.64% -84.89%
Depreciation, Depletion And Amortization $63.00K $54.65K $130.0K
YoY Change -51.54% -36.27% 116.67%
Cash From Operating Activities -$1.870M -$8.978M -$1.260M
YoY Change 48.44% 81.38% -4300.0%
INVESTING ACTIVITIES
Capital Expenditures -$4.140K $42.02K -$30.00K
YoY Change -86.2% 18.15%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0%
Cash From Investing Activities -$4.140K -$42.02K -$30.00K
YoY Change -86.2% -98.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 36.63K -$218.6K -120.0K
YoY Change -130.52% -100.91% 300.0%
NET CHANGE
Cash From Operating Activities -1.870M -$8.978M -1.260M
Cash From Investing Activities -4.140K -$42.02K -30.00K
Cash From Financing Activities 36.63K -$218.6K -120.0K
Net Change In Cash -1.838M -$9.239M -1.410M
YoY Change 30.34% -154.62% 320312271728132100.0%
FREE CASH FLOW
Cash From Operating Activities -$1.870M -$8.978M -$1.260M
Capital Expenditures -$4.140K $42.02K -$30.00K
Free Cash Flow -$1.866M -$9.020M -$1.230M
YoY Change 51.72% 80.93% -4200.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 dei Auditor Firm
AuditorFirmId
361
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
170000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7853759
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7853759
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7814572
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7814572
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5114000 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24000000 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7800000 USD
CY2021 bkyi Additional Income Of Cash Flow
AdditionalIncomeOfCashFlow
1000000 USD
CY2021Q4 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P4Y
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
633000 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
702000 USD
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0 USD
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0 USD
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
0 USD
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7754046 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16993096 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
970626 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
548049 USD
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
49500 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
60453 USD
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
82000 USD
CY2020Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
295000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
4940660 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
330947 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
216041 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
201507 USD
CY2021Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
0 USD
CY2020Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
512821 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
14012873 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
18941873 USD
CY2021Q4 bkyi Software License Rights Noncurrent
SoftwareLicenseRightsNoncurrent
48752 USD
CY2020Q4 bkyi Software License Rights Noncurrent
SoftwareLicenseRightsNoncurrent
58882 USD
CY2021Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
452821 USD
CY2020Q4 us-gaap Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
0 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
69168 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
81793 USD
CY2021Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
249012 USD
CY2020Q4 us-gaap Contract With Customer Asset Net Noncurrent
ContractWithCustomerAssetNetNoncurrent
165315 USD
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8712 USD
CY2020Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8712 USD
CY2021Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
113000 USD
CY2020Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
0 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
254100 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
487325 USD
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1298077 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1514146 USD
CY2021Q4 us-gaap Goodwill
Goodwill
1262526 USD
CY2020Q4 us-gaap Goodwill
Goodwill
1262526 USD
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3756168 USD
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3578699 USD
CY2021Q4 us-gaap Assets
Assets
17769041 USD
CY2020Q4 us-gaap Assets
Assets
22520572 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
427772 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
244158 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
828997 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
508487 USD
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
232000 USD
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
565355 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
657349 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
177188 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
234309 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1999312 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1876303 USD
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
67300 USD
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
44987 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
86974 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
264163 USD
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
154274 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
309150 USD
CY2021Q4 us-gaap Liabilities
Liabilities
2153586 USD
CY2020Q4 us-gaap Liabilities
Liabilities
2185453 USD
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
786 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
782 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
120190139 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
119844026 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104575470 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-99509689 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15615455 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
20335119 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
17769041 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22520572 USD
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5114489 USD
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2836782 USD
CY2021 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1672929 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
794826 USD
CY2021 us-gaap Gross Profit
GrossProfit
3441560 USD
CY2020 us-gaap Gross Profit
GrossProfit
2041956 USD
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6028360 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5848687 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2355056 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1396436 USD
CY2021 us-gaap Operating Expenses
OperatingExpenses
8383416 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
7245123 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-4941856 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-5203167 USD
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
4075 USD
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
30649 USD
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-50000 USD
CY2021 bkyi Investment Income Debt Security Reserve Expense
InvestmentIncomeDebtSecurityReserveExpense
60000 USD
CY2021 bkyi Government Grant Income
GovernmentGrantIncome
0 USD
CY2020 bkyi Government Grant Income
GovernmentGrantIncome
340819 USD
CY2021 us-gaap Interest Expense
InterestExpense
18000 USD
CY2020 us-gaap Interest Expense
InterestExpense
4343212 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-499076 USD
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-123925 USD
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4470820 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-5065781 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-9673987 USD
CY2021 us-gaap Dividends Paidinkind
DividendsPaidinkind
-0 USD
CY2020 us-gaap Dividends Paidinkind
DividendsPaidinkind
112686 USD
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5065781 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9786673 USD
CY2021 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.65
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.08
CY2021 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
7791741
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4700787
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-2285173 USD
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
28511 USD
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
277833 USD
CY2020 bkyi Stock Issued During Period Value Conversion Of Warrant
StockIssuedDuringPeriodValueConversionOfWarrant
5602595 USD
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3789000 USD
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
107576 USD
CY2020 bkyi Adjustments To Additional Paid In Capital Legal And Commitment Fees
AdjustmentsToAdditionalPaidInCapitalLegalAndCommitmentFees
2371223 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
641215 USD
CY2020 bkyi Deemed Dividend Related To Down Round Features
DeemedDividendRelatedToDownRoundFeatures
0 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
656008 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-9673987 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
20335119 USD
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
25536 USD
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
0 USD
CY2021 bkyi Adjustments To Additional Paid In Capital Legal Fees
AdjustmentsToAdditionalPaidInCapitalLegalFees
5228 USD
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
36630 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition
10680 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
278499 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-5065781 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
15615455 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-5065781 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-9673987 USD
CY2021 us-gaap Depreciation
Depreciation
54649 USD
CY2020 us-gaap Depreciation
Depreciation
85751 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
216069 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
120240 USD
CY2021 bkyi Amortization Of Software License Rights
AmortizationOfSoftwareLicenseRights
10130 USD
CY2020 bkyi Amortization Of Software License Rights
AmortizationOfSoftwareLicenseRights
0 USD
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-50000 USD
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-0 USD
CY2021 bkyi Reserve For Investment Security
ReserveForInvestmentSecurity
-60000 USD
CY2021 bkyi Reserve For Note Receivable
ReserveForNoteReceivable
-100000 USD
CY2021 bkyi Allowance For Doubtful Accounts
AllowanceForDoubtfulAccounts
-200000 USD
CY2020 bkyi Allowance For Doubtful Accounts
AllowanceForDoubtfulAccounts
-0 USD
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
18000 USD
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1425040 USD
CY2021 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
110681 USD
CY2020 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
152714 USD
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2166650 USD
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-499076 USD
CY2021 bkyi Amortization Of Beneficial Conversion Feature
AmortizationOfBeneficialConversionFeature
0 USD
CY2020 bkyi Amortization Of Beneficial Conversion Feature
AmortizationOfBeneficialConversionFeature
641215 USD
CY2021 bkyi Share Based Compensation Excluding Directors Fees
ShareBasedCompensationExcludingDirectorsFees
289179 USD
CY2020 bkyi Share Based Compensation Excluding Directors Fees
ShareBasedCompensationExcludingDirectorsFees
763584 USD
CY2021 bkyi Stock Based Fees To Directors And Consultants
StockBasedFeesToDirectorsAndConsultants
25536 USD
CY2020 bkyi Stock Based Fees To Directors And Consultants
StockBasedFeesToDirectorsAndConsultants
28511 USD
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
233225 USD
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
220915 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
672577 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
237257 USD
CY2021 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-10953 USD
CY2020 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-50488 USD
CY2021 bkyi Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
194378 USD
CY2020 bkyi Increase Decrease In Capitalized Contract Costs
IncreaseDecreaseInCapitalizedContractCosts
86510 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4609713 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-98172 USD
CY2021 bkyi Increase Decrease In Software License Rights
IncreaseDecreaseInSoftwareLicenseRights
-0 USD
CY2020 bkyi Increase Decrease In Software License Rights
IncreaseDecreaseInSoftwareLicenseRights
-14920 USD
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
14534 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
83625 USD
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
183614 USD
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-600399 USD
CY2021 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
320510 USD
CY2020 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-84415 USD
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-69681 USD
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-246876 USD
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-234310 USD
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-204315 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8978428 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4950108 USD
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42024 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
35568 USD
CY2021 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
-0 USD
CY2020 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
295000 USD
CY2021 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
-0 USD
CY2020 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
2000000 USD
CY2021 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
0 USD
CY2020 us-gaap Cash Acquired From Acquisition
CashAcquiredFromAcquisition
100747 USD
CY2021 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 USD
CY2020 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
512821 USD
CY2021 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
-0 USD
CY2020 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
512821 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-42024 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2229821 USD
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0 USD
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
22174425 USD
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
3958000 USD
CY2021 bkyi Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
36630 USD
CY2020 bkyi Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
0 USD
CY2021 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
-0 USD
CY2020 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
4509250 USD
CY2021 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5602595 USD
CY2021 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
-0 USD
CY2020 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2693021 USD
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
250000 USD
CY2020 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
250000 USD
CY2021 bkyi Payments For Legal Fees
PaymentsForLegalFees
5228 USD
CY2020 bkyi Payments For Legal Fees
PaymentsForLegalFees
-0 USD
CY2021 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 USD
CY2020 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
188737 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-218598 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
24094012 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-9239050 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16914083 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16993096 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
79013 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7754046 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16993096 USD
CY2021 us-gaap Interest Paid Net
InterestPaidNet
18000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
109426 USD
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2021 bkyi Business Combination Accounts Receivable Acquired
BusinessCombinationAccountsReceivableAcquired
0 USD
CY2020 bkyi Business Combination Accounts Receivable Acquired
BusinessCombinationAccountsReceivableAcquired
184792 USD
CY2021 bkyi Business Combination Prepaid Expenses Acquired
BusinessCombinationPrepaidExpensesAcquired
0 USD
CY2020 bkyi Business Combination Prepaid Expenses Acquired
BusinessCombinationPrepaidExpensesAcquired
9485 USD
CY2021 bkyi Business Combination Equipment Acquired
BusinessCombinationEquipmentAcquired
0 USD
CY2020 bkyi Business Combination Equipment Acquired
BusinessCombinationEquipmentAcquired
36467 USD
CY2021 bkyi Business Combination Intangible Assets Acquired
BusinessCombinationIntangibleAssetsAcquired
0 USD
CY2020 bkyi Business Combination Intangible Assets Acquired
BusinessCombinationIntangibleAssetsAcquired
1480000 USD
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0 USD
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
1262526 USD
CY2021 bkyi Business Combination Issuance Of Notes Payable
BusinessCombinationIssuanceOfNotesPayable
0 USD
CY2020 bkyi Business Combination Issuance Of Notes Payable
BusinessCombinationIssuanceOfNotesPayable
464000 USD
CY2021 bkyi Business Combination Accrued Expenses Acquired
BusinessCombinationAccruedExpensesAcquired
0 USD
CY2020 bkyi Business Combination Accrued Expenses Acquired
BusinessCombinationAccruedExpensesAcquired
20017 USD
CY2021 bkyi Business Combination Deferred Revenue Acquired
BusinessCombinationDeferredRevenueAcquired
0 USD
CY2020 bkyi Business Combination Deferred Revenue Acquired
BusinessCombinationDeferredRevenueAcquired
590000 USD
CY2021 bkyi Operating Lease Liability Assumed Under Asc842
OperatingLeaseLiabilityAssumedUnderAsc842
0 USD
CY2020 bkyi Operating Lease Liability Assumed Under Asc842
OperatingLeaseLiabilityAssumedUnderAsc842
141761 USD
CY2021 us-gaap Stock Issued1
StockIssued1
0 USD
CY2020 us-gaap Stock Issued1
StockIssued1
3789000 USD
CY2021 bkyi Sharebased Commitment Fees
SharebasedCommitmentFees
0 USD
CY2020 bkyi Sharebased Commitment Fees
SharebasedCommitmentFees
277833 USD
CY2021 bkyi Warrants Issued With Convertible Notes
WarrantsIssuedWithConvertibleNotes
0 USD
CY2020 bkyi Warrants Issued With Convertible Notes
WarrantsIssuedWithConvertibleNotes
1388339 USD
CY2021 bkyi Beneficial Conversion Feature
BeneficialConversionFeature
0 USD
CY2020 bkyi Beneficial Conversion Feature
BeneficialConversionFeature
641215 USD
CY2021 us-gaap Dividends Paidinkind
DividendsPaidinkind
0 USD
CY2020 us-gaap Dividends Paidinkind
DividendsPaidinkind
112686 USD
CY2021 bkyi Operational Costs Per Month
OperationalCostsPerMonth
735000 USD
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 5pt;"><em style="font: inherit;">2.</em> <i>Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 5pt; text-indent: 18pt;">Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) as set forth in the Financial Accounting Standards Board’s (FASB) Accounting Standards Codification (ASC) and consider the various staff accounting bulletins and other applicable guidance issued by the U.S. Securities and Exchange Commission (SEC). These accounting principles require us to make certain estimates, judgments and assumptions. The Company believes that the estimates, judgments and assumptions upon which it relies are reasonable based upon information available to us at the time that these estimates, judgments and assumptions are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities as of the date of the financial statements as well as the reported amounts of revenues and expenses during the periods presented. Certain significant accounting policies that contain subjective management estimates and assumptions include those related to revenue recognition, accounts receivable, inventory, intangible assets and long-lived assets, and income taxes. To the extent there are material differences between these estimates, judgments or assumptions and actual results, its consolidated financial statements will be affected. In many cases, the accounting treatment of a particular transaction is specifically dictated by GAAP and does <em style="font: inherit;">not</em> require management’s judgment in its application. There are also areas in which management’s judgment in selecting among available alternatives would <em style="font: inherit;">not</em> produce a materially different result.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021 bkyi Percentage Of Support And Maintenance Revenue To License Cost
PercentageOfSupportAndMaintenanceRevenueToLicenseCost
0.18 pure
CY2021Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1234411 USD
CY2020Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
561834 USD
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-50000 USD
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
0 USD
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
213785 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13785 USD
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
970626 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
548049 USD
CY2021 us-gaap Advertising Expense
AdvertisingExpense
527000 USD
CY2020 us-gaap Advertising Expense
AdvertisingExpense
494000 USD
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
314715 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
792095 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
28440
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0030 pure
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y6M
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.15 pure
CY2021 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5114489 USD
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2836782 USD
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
529000 USD
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
290000 USD
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
632655 USD
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
702336 USD
CY2021Q4 bkyi Factored Accounts Receivable Original Invoice Value
FactoredAccountsReceivableOriginalInvoiceValue
99000 USD
CY2021Q4 bkyi Factored Accounts Receivable Factored Amount
FactoredAccountsReceivableFactoredAmount
49500 USD
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
49500 USD
CY2020Q4 bkyi Factored Accounts Receivable Original Invoice Value
FactoredAccountsReceivableOriginalInvoiceValue
241715 USD
CY2020Q4 bkyi Factored Accounts Receivable Factored Amount
FactoredAccountsReceivableFactoredAmount
181262 USD
CY2020Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
60453 USD
CY2021 bkyi Factoring Arrangement Minimum Amount Of Accounts Receivable Per Quarter
FactoringArrangementMinimumAmountOfAccountsReceivablePerQuarter
150000 USD
CY2021 bkyi Factoring Fees
FactoringFees
50132 USD
CY2020 bkyi Factoring Fees
FactoringFees
98748 USD
CY2021Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
7057000 USD
CY2020Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
16020000 USD
CY2020Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
295000 USD
us-gaap Receivable With Imputed Interest Effective Yield Interest Rate
ReceivableWithImputedInterestEffectiveYieldInterestRate
0.05 pure
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
100000 USD
CY2021Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
295000 USD
CY2020Q4 us-gaap Notes Receivable Gross
NotesReceivableGross
295000 USD
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
100000 USD
CY2020Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
-0 USD
CY2021Q4 us-gaap Notes Receivable Net
NotesReceivableNet
195000 USD
CY2020Q4 us-gaap Notes Receivable Net
NotesReceivableNet
295000 USD
CY2021Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
82000 USD
CY2020Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
295000 USD
CY2021Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
113000 USD
CY2020Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
0 USD
CY2021Q4 bkyi Accrued Franchise Taxes Current
AccruedFranchiseTaxesCurrent
40000 USD
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
4798203 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
221130 USD
CY2021Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
142457 USD
CY2020Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
109817 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
4940660 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
330947 USD
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
254433 USD
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
87015 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1845080 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
330934 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1514146 USD
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1053043 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1011019 USD
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
983875 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
929226 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
69168 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
81793 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1845080 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
547003 USD
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1298077 USD
CY2020Q4 bkyi Accrued Franchise Taxes Current
AccruedFranchiseTaxesCurrent
0 USD
CY2021Q4 us-gaap Compensated Absences Liability
CompensatedAbsencesLiability
293297 USD
CY2020Q4 us-gaap Compensated Absences Liability
CompensatedAbsencesLiability
227147 USD
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
95738 USD
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
83738 USD
CY2020Q2 bkyi Stock Issued During Period Shares Issued For Due Diligence Fee
StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee
17071
CY2020Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
5.86
CY2021Q4 bkyi Accrued Employee Expenses Reimbursement Current
AccruedEmployeeExpensesReimbursementCurrent
76000 USD
CY2020Q4 bkyi Accrued Employee Expenses Reimbursement Current
AccruedEmployeeExpensesReimbursementCurrent
67000 USD
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
18548 USD
CY2020Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
17544 USD
CY2021Q4 bkyi Accrued Factoring Fees Current
AccruedFactoringFeesCurrent
495 USD
CY2020Q4 bkyi Accrued Factoring Fees Current
AccruedFactoringFeesCurrent
5495 USD
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
50486 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
20548 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
828997 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
508487 USD
CY2019Q3 bkyi Payments Of Stock Issuance Costs Commitment Fees
PaymentsOfStockIssuanceCostsCommitmentFees
50000 USD
CY2019Q3 bkyi Stock Issued During Period Shares Issued For Due Diligence Fee
StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee
33334
CY2019Q3 bkyi Stock Issued During Period Value Issued For Due Diligence Fee
StockIssuedDuringPeriodValueIssuedForDueDiligenceFee
400000 USD
CY2019Q3 bkyi Payments Of Stock Issuance Costs Banker Fees
PaymentsOfStockIssuanceCostsBankerFees
193500 USD
CY2019Q3 bkyi Payments Of Stock Issuance Costs Legal Fees
PaymentsOfStockIssuanceCostsLegalFees
71330 USD
CY2019Q3 bkyi Class Of Warrant Or Right Recorded As Debt Discount
ClassOfWarrantOrRightRecordedAsDebtDiscount
595662 USD
CY2020Q1 us-gaap Share Price
SharePrice
6.08
CY2020Q2 us-gaap Share Price
SharePrice
5.20
CY2020Q2 bkyi Stock Issued During Period Value Issued For Due Diligence Fee
StockIssuedDuringPeriodValueIssuedForDueDiligenceFee
133333 USD
CY2020Q2 bkyi Stock Issued During Period Shares Issued For Due Diligence Fee
StockIssuedDuringPeriodSharesIssuedForDueDiligenceFee
14368
CY2020Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
9.28
CY2020Q2 bkyi Stock Issued During Period Value Issued For Due Diligence Fee
StockIssuedDuringPeriodValueIssuedForDueDiligenceFee
100000 USD
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
255892 USD
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
239192 USD
CY2021 us-gaap Lease Cost
LeaseCost
255892 USD
CY2020 us-gaap Lease Cost
LeaseCost
239192 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
254100 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
487325 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
177188 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
234309 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
86974 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
264163 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
264162 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
498472 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y5M12D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y3M3D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0550 pure
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0550 pure
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
256977 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
235186 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
187594 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
89225 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12657 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
264162 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
276819 USD
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4689387
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2020Q1 bkyi Stock Issued During Period Shares Warrants Exercises
StockIssuedDuringPeriodSharesWarrantsExercises
121500
CY2020Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
12.00
CY2020Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1458000 USD
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
423559
CY2019Q4 bkyi Warrants Outstanding Exercise Price
WarrantsOutstandingExercisePrice
12.80
CY2019 bkyi Warrants Outstanding Weighted Average Remaining Life
WarrantsOutstandingWeightedAverageRemainingLife
P3Y11M8D
CY2020 bkyi Class Of Warrant Or Right Increase Due To Trigger Of Antidilution Provision Future
ClassOfWarrantOrRightIncreaseDueToTriggerOfAntidilutionProvisionFuture
27244
CY2020 bkyi Weighted Average Exercise Price Warrant Increase Due To Trigger Of Antidilution Provision Feature
WeightedAverageExercisePriceWarrantIncreaseDueToTriggerOfAntidilutionProvisionFeature
5.20
CY2020 bkyi Total Warrants Forfeited
TotalWarrantsForfeited
-0
CY2020 bkyi Weighted Average Exercise Price Warrants Forfeited
WeightedAverageExercisePriceWarrantsForfeited
0
CY2020 bkyi Total Warrants Expired
TotalWarrantsExpired
54066
CY2020 bkyi Weighted Average Exercise Price Warrants Expired
WeightedAverageExercisePriceWarrantsExpired
6.86
CY2020Q4 bkyi Warrants Outstanding Exercise Price
WarrantsOutstandingExercisePrice
6.04
CY2020 bkyi Warrants Outstanding Weighted Average Remaining Life
WarrantsOutstandingWeightedAverageRemainingLife
P4Y5M23D
CY2021 bkyi Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
0
CY2021 bkyi Weighted Average Exercise Price Warrants Granted
WeightedAverageExercisePriceWarrantsGranted
0
CY2021 bkyi Total Warrants Exercised
TotalWarrantsExercised
-0
CY2021 bkyi Weighted Average Exercise Price Warrants Exercised
WeightedAverageExercisePriceWarrantsExercised
0
CY2021 bkyi Total Warrants Forfeited
TotalWarrantsForfeited
-0
CY2021 bkyi Weighted Average Exercise Price Warrants Forfeited
WeightedAverageExercisePriceWarrantsForfeited
0
CY2021 bkyi Total Warrants Expired
TotalWarrantsExpired
-0
CY2021 bkyi Weighted Average Exercise Price Warrants Expired
WeightedAverageExercisePriceWarrantsExpired
0
CY2021Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
4689387
CY2021Q4 bkyi Warrants Outstanding Exercise Price
WarrantsOutstandingExercisePrice
6.04
CY2021 bkyi Warrants Outstanding Weighted Average Remaining Life
WarrantsOutstandingWeightedAverageRemainingLife
P3Y5M23D
CY2021Q4 us-gaap Share Price
SharePrice
2.21
CY2020Q4 us-gaap Share Price
SharePrice
3.52
CY2019Q4 us-gaap Share Price
SharePrice
4.00
CY2015Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
8681
CY2015Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
28.80
CY2015Q3 us-gaap Dividends Paidinkind
DividendsPaidinkind
41688 USD
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P2Y11M12D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
0 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
186538
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
18.04
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y8M23D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
218967
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.08
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
28440
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
5.04
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
-0
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4545
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
17.34
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
15588
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
29.17
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
227274
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.61
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M13D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
-0
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
3291
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.87
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
11522
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
39.13
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
212461
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.65
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
206283
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
16.98
CY2021 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
39.36
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
212461
CY2021Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
186538
CY2021Q4 us-gaap Share Price
SharePrice
2.21
CY2020Q4 us-gaap Share Price
SharePrice
3.52
CY2019Q4 us-gaap Share Price
SharePrice
4.00
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.16
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0 USD
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
252874 USD
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
899750 USD
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
75035 USD
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P0Y10M9D
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-5065781 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-9673987 USD
CY2021 us-gaap Dividends Paidinkind
DividendsPaidinkind
-0 USD
CY2020 us-gaap Dividends Paidinkind
DividendsPaidinkind
112686 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
135000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
81000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
75000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
474000 USD
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1149000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1073000 USD
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
10000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
14000 USD
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
75000 USD
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
65000 USD
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
14467000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
13337000 USD
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15891000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15016000 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2021 bkyi Effective Income Tax Reconciliation Permanent Differences
EffectiveIncomeTaxReconciliationPermanentDifferences
0 pure
CY2020 bkyi Effective Income Tax Reconciliation Permanent Differences
EffectiveIncomeTaxReconciliationPermanentDifferences
-0.09 pure
CY2021 bkyi Effective Income Tax Reconciliation Effect Of Net Operating Loss
EffectiveIncomeTaxReconciliationEffectOfNetOperatingLoss
-0.21 pure
CY2020 bkyi Effective Income Tax Reconciliation Effect Of Net Operating Loss
EffectiveIncomeTaxReconciliationEffectOfNetOperatingLoss
-0.12 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5065781 USD
CY2020 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9786673 USD

Files In Submission

Name View Source Status
0001437749-22-007930-index-headers.html Edgar Link pending
0001437749-22-007930-index.html Edgar Link pending
0001437749-22-007930.txt Edgar Link pending
0001437749-22-007930-xbrl.zip Edgar Link pending
bkyi-20211231.xsd Edgar Link pending
bkyi-20211231_cal.xml Edgar Link unprocessable
bkyi-20211231_def.xml Edgar Link unprocessable
bkyi-20211231_lab.xml Edgar Link unprocessable
bkyi-20211231_pre.xml Edgar Link unprocessable
bkyi20211231_10k.htm Edgar Link pending
bkyi20211231_10k_htm.xml Edgar Link completed
ex_351264.htm Edgar Link pending
ex_351265.htm Edgar Link pending
ex_351266.htm Edgar Link pending
ex_351267.htm Edgar Link pending
ex_351268.htm Edgar Link pending
ex_351269.htm Edgar Link pending
ex_353505.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending